…Background Pancreatic ductal adenocarcinoma (PDAC) is largely refractory to immune checkpoint blockade, owing to i…
pancreatic ductal adenocarcinoma (PDAC)
This disease is selected. Its supporting articles are shown below.
Articles mentioning pancreatic ductal adenocarcinoma (PDAC)
43 articles · page 1 of 4…Background Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers due to its aggressive bi…
…Background Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterised by remarkable c…
…0.01). Because CA19-9 is an established prognostic indicator in PDAC, this imbalance represents a source of residual confounding tha…
…Background The application of the novel KRAS G12D inhibitor in pancreatic ductal adenocarcinoma (PDAC) is currently hindered by adaptive resistance. Metabolic reprogr…
…Perineural invasion (PNI) is a hallmark pathological feature of pancreatic ductal adenocarcinoma (PDAC) and is strongly associated with tumor recurrence, metastasis, a…
…Background Pancreatic ductal adenocarcinoma (PDAC) can present as solid masses with cystic components that may be …
…Background Pancreatic ductal adenocarcinoma (PDAC) remains a major challenge for immunotherapy due to its immunolo…
…Background Pancreatic ductal adenocarcinoma (PDAC) frequently invades adjacent peripancreatic adipose tissue, yet …
…Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy that frequently presents at a…
…Background Pancreatic ductal adenocarcinoma (PDAC), the most common malignant type of pancreatic cancer, is charac…
… (VM) is a non-endothelial vascularisation programme sustaining pancreatic ductal adenocarcinoma (PDAC) perfusion and metastasis, yet its regulators and therapeutic vu…